| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/17/2013 | CN103041312A Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof |
| 04/17/2013 | CN103041293A Traditional Chinese medicine decoction for treating yin-deficiency internal-heat type lung cancer |
| 04/17/2013 | CN103041291A Traditional Chinese medicine for treating lung cancer |
| 04/17/2013 | CN103041290A Traditional Chinese medicine for treating lung cancer |
| 04/17/2013 | CN103041227A Liver benefiting powder |
| 04/17/2013 | CN103041163A Traditional Chinese medicine for treating esophagus cancer and gastric cancer |
| 04/17/2013 | CN103041115A Composition for treating leukemia |
| 04/17/2013 | CN103041109A Pills for treating lung cancer by using tofieldia divergens |
| 04/17/2013 | CN103041095A Preparation method of Chinese yam capsules |
| 04/17/2013 | CN103041041A Traditional Chinese medicine for treating qi-stagnation and blood-stasis type liver cancer |
| 04/17/2013 | CN103040990A Pharmaceutical composition for treating malignant tumors and preparation method thereof |
| 04/17/2013 | CN103040978A Pawpaw extract with anti-cancer activity, and preparation method and application thereof |
| 04/17/2013 | CN103040968A Anticancer Yanshouling |
| 04/17/2013 | CN103040941A Supercritical extraction pollen extractive as well as preparation and application thereof |
| 04/17/2013 | CN103040938A Body-strengthening and detoxifying traditional Chinese medicinal cordyceps formula |
| 04/17/2013 | CN103040914A Preparation method of eucommia ulmoides seed oil nano emulsion injection |
| 04/17/2013 | CN103040908A Method for extracting anticancer substances from sweet potato stalks |
| 04/17/2013 | CN103040895A Maca powder with bioactivity fully reserved, and preparation method and preparation of maca powder |
| 04/17/2013 | CN103040893A Pharmaceutical composition for treating liver cancers and preparation method thereof |
| 04/17/2013 | CN103040878A Anti-tumor Chinese herbal preparation and preparation method thereof |
| 04/17/2013 | CN103040877A Preparation method of cordyceps sinensis micropowder lozenges |
| 04/17/2013 | CN103040864A Medical application of selenium phosphate compound |
| 04/17/2013 | CN103040863A Disodium clodronate liposome injection |
| 04/17/2013 | CN103040855A Pharmaceutical composition of fludarabine phosphate and preparation method thereof |
| 04/17/2013 | CN103040850A Methionine-antitumor compound medicine and preparation method thereof |
| 04/17/2013 | CN103040847A Novel application of small molecule compound ZZY-0001 in preparing antitumor drugs |
| 04/17/2013 | CN103040836A Use of moclobemide in prostatic cancer resistance and pharmaceutical preparation of moclobemide |
| 04/17/2013 | CN103040834A Pemetrexed disodium for injection and preparation method thereof |
| 04/17/2013 | CN103040827A Application of antagonist SR140333 of neurokinin receptor in hepatoma treatment |
| 04/17/2013 | CN103040824A Signal channel inhibiting agent as well as preparation method and application thereof |
| 04/17/2013 | CN103040823A Application of vinpocetine in preparation of anti-angiogenic medicament |
| 04/17/2013 | CN103040800A Application of gemfibrozil in preparation of anti-angiogenic medicaments |
| 04/17/2013 | CN103040790A Preparation method of wild cactus polysaccharide poly(lactic-co-glycolic acid) (PLGA) microcapsules |
| 04/17/2013 | CN103040785A Permeable gastric retention tablets and preparation method thereof |
| 04/17/2013 | CN103040766A Drug composition containing pamidronate disodium compound |
| 04/17/2013 | CN103040764A Bleomycin hydrocloride lipidosome injection |
| 04/17/2013 | CN103040757A Core-shell drug nano-particles, as well as preparation method and application thereof |
| 04/17/2013 | CN103040756A Preparation method of mPEG epirubicin hydrochloride magnetic liposome |
| 04/17/2013 | CN103040755A APARPAR polypeptide-modified invisible liposome and drug delivery system |
| 04/17/2013 | CN103040754A Resveratrol nano-liposome and preparation method thereof |
| 04/17/2013 | CN103040748A Pemetrexed disodium liposome injection |
| 04/17/2013 | CN103040741A Precursor suspension of lyotropic liquid crystal and preparation method thereof |
| 04/17/2013 | CN103040739A Drug composition containing docetaxel compound |
| 04/17/2013 | CN103040724A Nano drug delivery system containing polymer and phospholipid and preparation method thereof |
| 04/17/2013 | CN102640918B Preparation method of ant, burdock and ganoderma lucidum liquid |
| 04/17/2013 | CN102626416B Application of tamoxifen, rapamycin and ginsenoside Rg3 composition in preparing medicaments for treating liver cancer |
| 04/17/2013 | CN102614201B Combretastain diphosphate tetrasodium composition for injection and preparation method thereof |
| 04/17/2013 | CN102488909B Application of therapeutic isotope labeled Evans blue and its derivatives in preparing tumor targeted radiotherapy medicaments |
| 04/17/2013 | CN102423384B Traditional Chinese drug preparation for treating lung cancer, and preparation method thereof |
| 04/17/2013 | CN102416183B Application of micro ribose nucleic acid (RNA) (miR)-297b |
| 04/17/2013 | CN102416182B Application of micro ribose nucleic acid (RNA) (miR)-574-5p |
| 04/17/2013 | CN102416178B Water-soluble non-aggregated alkoxy-substituted phthalocyanine-silica nanometer particle |
| 04/17/2013 | CN102416059B Medicinal composition for treating colon cancer |
| 04/17/2013 | CN102349874B Imatinib mesylate composition and preparation method thereof |
| 04/17/2013 | CN102335182B Application of triacetylglucal in medicine preparation |
| 04/17/2013 | CN102321187B Method for extracting whole peptidoglycan from bifidobacterium longum NQ-1501 |
| 04/17/2013 | CN102302782B Preparation method of hepatoma carcinoma cell-targeted polyamido-amine dendrimer support |
| 04/17/2013 | CN102295648B Calcium cantharidinate and preparation method thereof |
| 04/17/2013 | CN102293987B Medicine for treating thyroid adenoma |
| 04/17/2013 | CN102250110B Magnesium cantharidate and preparation method thereof |
| 04/17/2013 | CN102247365B Medical application of compound and medicament preparation thereof |
| 04/17/2013 | CN102247335B Bufalin dry powder inhalant as well as preparation method and application thereof |
| 04/17/2013 | CN102210712B Bufo bufo gargarizans cantor skin extract dry powder inhalant and preparation method and use thereof |
| 04/17/2013 | CN102180883B Substituted porphyrin gold (III) compounds with anticancer activity and preparation method thereof |
| 04/17/2013 | CN102174075B Lipopeptide compound as well as compositions, preparation method and application thereof |
| 04/17/2013 | CN102145177B Method for preparing folate molecular targeted magnetic nanometer medicine carrier and targeting gene medicine |
| 04/17/2013 | CN102134207B Urea compound and preparation method and application thereof |
| 04/17/2013 | CN102058871B Chinese medicine effective part composition with antitumor effect and preparation method thereof |
| 04/17/2013 | CN102048727B Application of formononetin in preparing of medicament for restricting angiogenesis |
| 04/17/2013 | CN102038641B Preparation method of liposome medicine with outer layer modified by hydrophilic polymer |
| 04/17/2013 | CN101984056B RNA interference target RNA of long non-coding RNA related to human melanoma cells and application thereof |
| 04/17/2013 | CN101973935B Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 04/17/2013 | CN101967105B Beta-hydroxy protected didecyl quaternary ammonium salt with anticancer activity and preparation method thereof |
| 04/17/2013 | CN101948694B Rare earth upconversion nano crystal/silver difunctional composite nano material, preparation method thereof and application thereof in cancer detection and treatment |
| 04/17/2013 | CN101925584B Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis |
| 04/17/2013 | CN101921711B Alternarlactam and preparation method and application thereof |
| 04/17/2013 | CN101903389B Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 04/17/2013 | CN101875688B Folic acid modification step of method for preparing recombinant tumor specific apoptosis factor and application of products of recombinant tumor specific apoptosis factor |
| 04/17/2013 | CN101843663B Preparation method of extract package of volatile oil heavier than water |
| 04/17/2013 | CN101775078B Sea urchin content polysaccharide having anti-tumor and immunological activities and preparation method |
| 04/17/2013 | CN101721394B Granisetron and/or hydrochloride patch thereof |
| 04/17/2013 | CN101709078B Immune-modulating peptide |
| 04/17/2013 | CN101679411B MAPK/ERK kinase inhibitors |
| 04/17/2013 | CN101671376B Alkannin acetyl glucose and preparation method and application thereof |
| 04/17/2013 | CN101652363B Thiazolyl compounds useful as kinase inhibitors |
| 04/17/2013 | CN101647850B New application of chemical component of eucommia bark used as plant estrogen |
| 04/17/2013 | CN101623295B Medicine for treating bladder neoplasms |
| 04/17/2013 | CN101589801B Process for manufacturing red ginseng honey slice |
| 04/17/2013 | CN101586167B Diagnosis reagent for primary hepatocellular carcinoma, reagent kit and prevention and cure medicaments |
| 04/17/2013 | CN101456824B Alpha-amido-N-substituted amide compounds, medicament composition containing the same and use thereof |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/17/2013 | CN101389622B Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 04/17/2013 | CN101289510B 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 04/17/2013 | CN101239929B Trichostatin A derivatives, preparation method and use thereof |
| 04/17/2013 | CN101189249B Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 04/17/2013 | CN101166732B Cyanopyridine derivative and use thereof as medicine |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420665 Anti-cancer compounds |